Rothschild Investment LLC Cor Medix Inc. Transaction History
Rothschild Investment LLC
- $1.6 Trillion
- Q2 2025
A detailed history of Rothschild Investment LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 170 shares of CRMD stock, worth $1,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170
Previous 120
41.67%
Holding current value
$1,955
Previous $739,000
183.36%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
183Shares Held
32.6MCall Options Held
881KPut Options Held
583K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.7 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...